Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health ...

This blog post concludes a five-part series I ran this week on some of the keys intersecting AI and compliance. Yesterday, I wrote that businesses must proactively address the potential for bias at ...

Current solutions for remote health monitoring can be seen as invasive by patients and mostly do single variant intermittent tracking. FDA clearance brings one of Europe’s most advanced real-time ...

Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...

Historically, cybersecurity models have been largely reactive. Organizations would assess vulnerabilities at specified intervals, typically following a security incident or a scheduled audit. While ...